New Delhi, March 23 A study has identified a new biomarker for schizophrenia, which could also serve as a target for drugs to treat cognitive symptoms such as disorganized thinking or executive function.Schizophrenia is a mental health disorder characterized by an impaired ability to perceive...
biomarker
brain circuits
brain plasticity
cacna2d1
cerebrospinal fluid
clinical trials
cognitive symptoms
drug development
mental health disorders
neuroscience
peptide therapy
protein
research study
schizophrenia
synapses
New Delhi, March 11 A study has found that a woman's risk of developing dementia may be predicted 25 years before symptoms begin through a test of a blood-based biomarker called 'phosphorylated tau 217' – a protein linked to the brain changes seen in Alzheimer's disease.Higher levels of...
alzheimer's disease
apoe e4
biomarker
blood test
cognitive impairment
cognitive outcomes
dementia
genetics
hormone therapy
mild cognitive impairment
phosphorylated tau 217
risk prediction
university of california san diego
women's health
women's health initiative memory study